Optimal Implantation Depth With Self-Expanding TAVR? Success May Prove Elusive
The study’s researchers call for a uniform method of assessing this parameter.
Related Articles
LuX-Valve TTVR Device Provides Favorable 1-Year Results
Where this device will fit in with other emerging options remains to be seen, but it might hold an advantage in large annuli.
Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK
The novel dissolvable therapy had a 93.2% probability of being cost-effective at a modest willingness-to-pay level.
HRS, ACC Lay Out Principles for Same-Day Discharge After Catheter Ablation
With careful consideration of several factors, many patients can avoid an overnight stay, reducing costs without sacrificing safety.
Beyond the Data: Medical Mission Work
Mamas Mamas talks with Partho Sengupta and Tesfaye Telila about the complexities involved in medical missions around the world.
Rox Heart Replay: Getting to Know Robert Harrington
From June 2023: Roxana Mehran talks with Robert Harrington, the new Dean of Weill Cornell Medicine, about his move to New York and plans for…
Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE
Ten years after learning their polygenic risk score, patients had fewer events—perhaps due to greater use of statin therapy.
Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices
Limus-based devices, rather than being a substitute for paclitaxel as they were once seen, are coming of age in peripheral disease.
PFO, Risk Factors Both Exert Influence in Younger Cryptogenic Stroke Patients
Nontraditional risk factors, particularly migraine with aura, play a major role in patients under 50 years old.
Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI
Not everyone is sold on the benefits of early ezetimibe use, especially given the modest effect seen in IMPROVE-IT.
Solid Durability Seen With Surgical Resilia Tissue Aortic Valve
The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.